BIBLIOGRAPHIE
55
Cavallo J.-D, Fabre R, Jelhi F., Rapp C. and Garrabé E., 2004. Béta-lactamines (beta-lactam antibiotics).
EMC-Maladies infectieuses 1 :129-202
Cavallo J.-D., Mérens A., 2008. Pseudomonas aeruginosa et bêta-lactamines à l’heure de l’Europe
Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe. Pathologie Biologie 56 (2008) 435–
438.
Chelossi E., Vezzulli L., Milano A., Branzoni M., Fabiano M., Riccardi G., Banat I.M., 2003. Antibiotic
resistance of benthic bacteria in fish-farm and control sediments of the Western Mediterranean. Aquaculture 219
83 –97
Courvalin P., Goldstein F., Filippon A. et Sirot J., 1985. L’antibiogramme,1
ière édition. MCP édition, Paris.
Courvalin P., Drugeon H., Flandrois J.P., Goldsteine F., 1991. Bactériolocidie. Edition MALOINE. P , 13-21.
F
F F
F
Frère J.M., 1995. Bêta-lactamases and bacterial resistance to antibiotics. Molecular microbiology. 16 : 385-395.
G
G G
G
Gaillot.O, 2007. Caractéristiques et mode d’action des antibiotiques,
Goni-Urriza M., Capdepuy M., Arpin C., Raymond N., Caumette P. et Quentin C., 2000. Impact
of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp.
Applied and Environmental Microbiology 66: 125-32.
H
H H
H
Hancock R.E.W. et Speert D.P. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and
impact on treatment. Harcourt Publishers Ltd Drug Resistance Updates (2000) 3, 247–255.
Hata, M., Fujii Y., Tanaka Y., Ishikawa H., Ishii M., Neya S., Tsuda M. et Hoshino T., 2006. Substrate
Deacylation Mechanisms of Serine-b-lactamases. Biol. Pharm. Bull. 29: 2151-2159
Heritage J., M’zali F.H., Gascoyne-Binzi D. et Hawkey M.P. , 1999. Evolution and spread of SHV extentedSpectrum b-lactamses in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 44 : 309-318.
I
I I
I
Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R, Arlet G., 2008.
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother. 2008
Jul;62(1):133-6. Epub 2008 Apr 1.
J
J J
J
Jacoby, G. A., et A. A. Medeiros (1991). More extended-spectrum β-lactamases. Antimicrob. Agents.
Chemother. 35: 1697-1704
Jacoby G.A. et Medeiros A.A., 1999. More extented-spectrum b-lactamses. In Heritage J., 1999.
Jacoby G.A., 2009. AmpC Β-Lactamases. Clinical Microbiology .Revue .JANVIER 2009, Pages
161-182.
Jarlier.V., 1997. Mécanismes de résistance aux antibiotiques. Médecine Thépapeutique, Hors série n°1. 46-58.
55
Cavallo J.-D, Fabre R, Jelhi F., Rapp C. and Garrabé E., 2004. Béta-lactamines (beta-lactam antibiotics).
EMC-Maladies infectieuses 1 :129-202
Cavallo J.-D., Mérens A., 2008. Pseudomonas aeruginosa et bêta-lactamines à l’heure de l’Europe
Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe. Pathologie Biologie 56 (2008) 435–
438.
Chelossi E., Vezzulli L., Milano A., Branzoni M., Fabiano M., Riccardi G., Banat I.M., 2003. Antibiotic
resistance of benthic bacteria in fish-farm and control sediments of the Western Mediterranean. Aquaculture 219
83 –97
Courvalin P., Goldstein F., Filippon A. et Sirot J., 1985. L’antibiogramme,1
ière édition. MCP édition, Paris.
Courvalin P., Drugeon H., Flandrois J.P., Goldsteine F., 1991. Bactériolocidie. Edition MALOINE. P , 13-21.
F
F F
F
Frère J.M., 1995. Bêta-lactamases and bacterial resistance to antibiotics. Molecular microbiology. 16 : 385-395.
G
G G
G
Gaillot.O, 2007. Caractéristiques et mode d’action des antibiotiques,
Goni-Urriza M., Capdepuy M., Arpin C., Raymond N., Caumette P. et Quentin C., 2000. Impact
of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp.
Applied and Environmental Microbiology 66: 125-32.
H
H H
H
Hancock R.E.W. et Speert D.P. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and
impact on treatment. Harcourt Publishers Ltd Drug Resistance Updates (2000) 3, 247–255.
Hata, M., Fujii Y., Tanaka Y., Ishikawa H., Ishii M., Neya S., Tsuda M. et Hoshino T., 2006. Substrate
Deacylation Mechanisms of Serine-b-lactamases. Biol. Pharm. Bull. 29: 2151-2159
Heritage J., M’zali F.H., Gascoyne-Binzi D. et Hawkey M.P. , 1999. Evolution and spread of SHV extentedSpectrum b-lactamses in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 44 : 309-318.
I
I I
I
Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R, Arlet G., 2008.
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother. 2008
Jul;62(1):133-6. Epub 2008 Apr 1.
J
J J
J
Jacoby, G. A., et A. A. Medeiros (1991). More extended-spectrum β-lactamases. Antimicrob. Agents.
Chemother. 35: 1697-1704
Jacoby G.A. et Medeiros A.A., 1999. More extented-spectrum b-lactamses. In Heritage J., 1999.
Jacoby G.A., 2009. AmpC Β-Lactamases. Clinical Microbiology .Revue .JANVIER 2009, Pages
161-182.
Jarlier.V., 1997. Mécanismes de résistance aux antibiotiques. Médecine Thépapeutique, Hors série n°1. 46-58.
